When two hemorrhagic fever outbreaks erupted simultaneously in May 2026, they exposed a critical blind spot in global outbreak response: applying identical contact tracing protocols to pathogens with fundamentally different transmission biology can undermine containment. The contrast between an Andes virus cluster aboard an expedition cruise ship and a concurrent Bundibugyo ebolavirus surge in Central Africa offers a rare natural experiment in comparative outbreak epidemiology.
The MV Hondius Andes virus (ANDV) outbreak generated 13 cases — 12 laboratory-confirmed — with three fatalities, while contact investigators tracked more than 600 exposed individuals across 32 countries from 23 nationalities. Critically, sustained person-to-person transmission extended across three generations from a single index case, and at least one contact tested PCR-positive without symptoms before subsequently developing clinical disease. This pre-symptomatic RNA detection challenges the long-held assumption that ANDV infectiousness is tightly coupled to symptom onset. The concurrent Bundibugyo virus (BDBV) outbreak exceeded 1,000 confirmed cases and 250 deaths across the Democratic Republic of the Congo and Uganda, yet current evidence does not support pre-symptomatic transmission as a meaningful driver in BDBV dynamics — a distinction with profound implications for the timing and intensity of contact monitoring windows.
The comparative framework proposed here is analytically significant. ANDV's secondary attack rate data from Chilean endemic regions (5.7% over 2021–2025) and Argentina's historical cluster outbreaks at El Bolsón (1996) and Epuyén (2018) establish a genomically-supported pattern of interpersonal spread that ebolavirus contact tracing models, built around symptomatic infectiousness, cannot adequately capture. The therapeutic pipeline context — including favipiravir, tocilizumab, and icatibant — further differentiates management pathways. The key limitation here is that pre-symptomatic ANDV infectiousness remains unquantified; PCR positivity does not equal transmissibility. This perspective-level analysis lacks the statistical power of a controlled study, but its operational implications for international outbreak preparedness are immediate and actionable at the public health infrastructure level.